JP2023504773A5 - - Google Patents
Info
- Publication number
- JP2023504773A5 JP2023504773A5 JP2022525579A JP2022525579A JP2023504773A5 JP 2023504773 A5 JP2023504773 A5 JP 2023504773A5 JP 2022525579 A JP2022525579 A JP 2022525579A JP 2022525579 A JP2022525579 A JP 2022525579A JP 2023504773 A5 JP2023504773 A5 JP 2023504773A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- nucleic acid
- adeno
- capsid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19206603.3 | 2019-10-31 | ||
| EP19206603 | 2019-10-31 | ||
| PCT/EP2020/080704 WO2021084133A1 (en) | 2019-10-31 | 2020-11-02 | Aav vector variants for ocular gene delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504773A JP2023504773A (ja) | 2023-02-07 |
| JP2023504773A5 true JP2023504773A5 (https=) | 2023-11-10 |
| JP7791546B2 JP7791546B2 (ja) | 2025-12-24 |
Family
ID=68426130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525579A Active JP7791546B2 (ja) | 2019-10-31 | 2020-11-02 | 眼遺伝子送達のためのａａｖベクター変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12509705B2 (https=) |
| EP (1) | EP4051694B1 (https=) |
| JP (1) | JP7791546B2 (https=) |
| KR (1) | KR20220093163A (https=) |
| CN (1) | CN114729009A (https=) |
| AU (1) | AU2020373326A1 (https=) |
| CA (1) | CA3157464A1 (https=) |
| IL (1) | IL291240A (https=) |
| WO (1) | WO2021084133A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240252679A1 (en) * | 2021-05-28 | 2024-08-01 | Shanghai Regenelead Therapies Co., Ltd. | Recombinant adeno-associated virus having variant capsid, and application thereof |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| AU2023220219A1 (en) | 2022-02-17 | 2024-09-05 | Skyline Therapeutics Limited | Recombinant adeno-associated virus with modified aav capsid polypeptides |
| WO2024191778A1 (en) | 2023-03-10 | 2024-09-19 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| AU2024276934A1 (en) * | 2023-05-23 | 2025-12-18 | Innovec Biotherapeutics | Adeno-associated virus capsid protein, adeno-associated virus containing same, vector and use thereof |
| AU2024332181A1 (en) | 2023-08-31 | 2026-02-12 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2025051292A1 (zh) * | 2024-01-16 | 2025-03-13 | 广州译码基因科技有限公司 | 提高aav病毒对眼组织感染能力的衣壳蛋白突变体及其应用 |
| CN118459557B (zh) * | 2024-01-16 | 2024-11-22 | 沈阳兴齐眼药股份有限公司 | 提高aav病毒视网膜穿透能力的衣壳蛋白突变体及其应用 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026033140A1 (en) * | 2024-08-09 | 2026-02-12 | Revvity Gene Delivery Gmbh | Variant aav capsid polypeptides targeting the eye |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284746A (en) | 1990-02-08 | 1994-02-08 | Zymogenetics, Inc. | Methods of producing hybrid G protein-coupled receptors |
| ES2308779T3 (es) | 1995-07-26 | 2008-12-01 | Astrazeneca Ab | Receptores quimericos y metodos para identificar compuestos activos en los receptores de glutamato metabotropico y el uso de tales compuestos en el tratamiento de trastornos y enfermedades neurologicas. |
| US20040248202A1 (en) | 1998-09-03 | 2004-12-09 | Wisconsin Alumni Research Foundation | Bacteriorhodopsin/G protein-coupled receptor chimeras |
| US9284363B2 (en) | 2006-07-26 | 2016-03-15 | Case Western Reserve University | System and method for controlling G-protein coupled receptor pathways |
| MY152003A (en) | 2008-05-29 | 2014-08-15 | Univ Leland Stanford Junior | Cell line, system and method for optical control of secondary messengers |
| WO2012051599A2 (en) | 2010-10-15 | 2012-04-19 | Eos Neuroscience, Inc. | Modulation neural pathways |
| CN105755044A (zh) * | 2011-04-22 | 2016-07-13 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体及其使用方法 |
| EP3029063B1 (en) | 2011-06-24 | 2019-10-16 | Arctos Medical AG | Light-sensitive chimeric gpcr protein |
| CA2839938A1 (en) | 2011-06-28 | 2013-01-03 | University Of Rochester | Photoactivatable receptors and their uses |
| US20140087463A1 (en) | 2012-09-25 | 2014-03-27 | The Washington University | Optical control of cell signaling |
| EP3024497B1 (en) | 2013-07-26 | 2021-01-13 | University of Iowa Research Foundation | Methods and compositions for treating brain diseases |
| BR112016017817A2 (pt) | 2014-02-06 | 2017-10-10 | Genzyme Corp | composições e métodos para o tratamento e a prevenção de degeneração macular |
| US20170007720A1 (en) | 2014-02-21 | 2017-01-12 | University Of Florida Research Foundation, Inc. | Methods and compositions for gene delivery to on bipolar cells |
| GB201403260D0 (en) | 2014-02-25 | 2014-04-09 | Univ Manchester | Treatment of retinal degeneration using gene therapy |
| EP4678754A3 (en) | 2014-03-11 | 2026-04-08 | Wayne State University | A modified mglur6 promoter and methods of use |
| AU2016219789B2 (en) | 2015-02-20 | 2021-03-25 | Fondazione Telethon | Methods and compositions for treating genetic eye diseases |
| US11021519B2 (en) * | 2015-03-02 | 2021-06-01 | Adverum Biotechnologies, Inc. | Compositions and methods for intravitreal delivery of polynucleotides to retinal cones |
| US10533187B2 (en) | 2015-03-18 | 2020-01-14 | University Of Florida Research Foundation, Incorporated | Methods and compositions for restoration of cone function in BCM |
| CN105154470A (zh) | 2015-07-22 | 2015-12-16 | 华东师范大学 | 一种高效筛查g蛋白-偶联受体表达的融合基因构建方法 |
| US11364308B2 (en) * | 2016-05-13 | 2022-06-21 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| AU2017302013B2 (en) | 2016-07-29 | 2022-05-26 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| EP4653537A3 (en) | 2016-09-02 | 2026-01-07 | Keio University | Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function |
| US10376265B2 (en) | 2017-01-30 | 2019-08-13 | Ethicon Llc | Non-magnetic fragmentable tissue compression devices |
| CA3053154A1 (en) | 2017-06-30 | 2019-01-03 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsids and methods of use thereof |
| US12043848B2 (en) * | 2017-10-16 | 2024-07-23 | Vigeneron Gmbh | AAV vectors |
| JP7029160B2 (ja) | 2017-11-24 | 2022-03-03 | 公立大学法人大阪 | 新規な光受容タンパク質 |
| CN111770999A (zh) * | 2017-11-27 | 2020-10-13 | 4D分子治疗有限公司 | 腺相关病毒变体衣壳和用于抑制血管生成的应用 |
| WO2020148913A1 (ja) | 2019-01-18 | 2020-07-23 | 俊英 栗原 | 網膜疾患の予防および進行抑制、視覚認知行動機能の改善、および視覚機能強化 |
| CN115052988A (zh) | 2019-11-18 | 2022-09-13 | 伯尔尼大学 | 用于眼部基因递送的给光型双极细胞特异性启动子 |
| US20240174743A1 (en) | 2019-11-29 | 2024-05-30 | Universität Bern | Chimeric opsin gpcr proteins |
-
2020
- 2020-11-02 CN CN202080074852.9A patent/CN114729009A/zh active Pending
- 2020-11-02 KR KR1020227018274A patent/KR20220093163A/ko not_active Ceased
- 2020-11-02 JP JP2022525579A patent/JP7791546B2/ja active Active
- 2020-11-02 US US17/755,434 patent/US12509705B2/en active Active
- 2020-11-02 CA CA3157464A patent/CA3157464A1/en active Pending
- 2020-11-02 WO PCT/EP2020/080704 patent/WO2021084133A1/en not_active Ceased
- 2020-11-02 AU AU2020373326A patent/AU2020373326A1/en not_active Abandoned
- 2020-11-02 EP EP20841660.2A patent/EP4051694B1/en active Active
-
2022
- 2022-03-09 IL IL291240A patent/IL291240A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023504773A5 (https=) | ||
| KR102298579B1 (ko) | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 | |
| RU2697444C2 (ru) | Вариант aav, композиции и способы, в которых он используется, а также способы его применения для переноса генов в клетки, органы и ткани | |
| JP7791546B2 (ja) | 眼遺伝子送達のためのａａｖベクター変異体 | |
| US20240091383A1 (en) | Synergistic effect of smn1 and mir-23a in treating spinal muscular atrophy | |
| KR20150005521A (ko) | 세포, 기관 및 조직으로의 유전자 전이를 위한 ａａｖ 벡터 조성물 및 방법 | |
| RU2020137429A (ru) | Лечение пигментного ретинита | |
| CN104087591A (zh) | 用于基因治疗的修饰的因子viii和因子ix基因和载体 | |
| US12359219B2 (en) | Transgene cassettes designed to express a human MECP2 gene | |
| JP2022531861A5 (https=) | ||
| AU2019360937A1 (en) | Expression vectors for large-scale production of rAAV in the baculovirus/Sf9 system | |
| JP2022512589A5 (https=) | ||
| WO2024240113A1 (zh) | 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用 | |
| CN114276419B (zh) | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 | |
| JP2024543994A (ja) | 硝子体内投与用の機能性ａａｖカプシド | |
| CN117003833A (zh) | 肝脏特异性的腺相关病毒血清型及应用 | |
| WO2024138833A1 (zh) | 一种改造的重组凝血因子viii及其应用 | |
| CN118613590A (zh) | 用于玻璃体内施用的功能性aav衣壳 | |
| US20240076691A1 (en) | Codon-optimized nucleic acid encoding the fix protein | |
| RU2716999C1 (ru) | Способ получения рекомбинантных аденоассоциированных вирусов для использования в генной терапии | |
| RU2837753C2 (ru) | Вариант aav, композиции и способы, в которых он используется, а также способы его применения для переноса генов в клетки, органы и ткани | |
| WO2025065890A1 (zh) | 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用 | |
| WO2025193808A1 (en) | Cns-specific gene replacement therapy for genetic forms of als/ftd | |
| HK40109360A (zh) | 用於玻璃体内施用的功能性aav衣壳 | |
| OA21365A (en) | Synergistic effect of SMN1 and MIR-23A in treating spinal muscular atrophy. |